Search by Drug Name or NDC

    NDC 70000-0126-01 Nasal Decongestant PE 10 mg/1 Details

    Nasal Decongestant PE 10 mg/1

    Nasal Decongestant PE is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by Cardinal Health 110, LLC. DBA Leader. The primary component is PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 70000-0126
    Product ID 70000-0126_0d1ab708-9b21-4ac6-8846-fee9967b09d4
    Associated GPIs 42101040100310
    GCN Sequence Number 058496
    GCN Sequence Number Description phenylephrine HCl TABLET 10 MG ORAL
    HIC3 B6V
    HIC3 Description DECONGESTANTS, ORAL
    GCN 23944
    HICL Sequence Number 002087
    HICL Sequence Number Description PHENYLEPHRINE HCL
    Brand/Generic Generic
    Proprietary Name Nasal Decongestant PE
    Proprietary Name Suffix Maximum Strength
    Non-Proprietary Name Phenylephrine HCl
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 10
    Active Ingredient Units mg/1
    Substance Name PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Cardinal Health 110, LLC. DBA Leader
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M012
    Listing Certified Through 2024-12-31

    Package

    NDC 70000-0126-01 (70000012601)

    NDC Package Code 70000-0126-1
    Billing NDC 70000012601
    Package 1 BLISTER PACK in 1 CARTON (70000-0126-1) / 18 TABLET, FILM COATED in 1 BLISTER PACK
    Marketing Start Date 2005-01-14
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.05079
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description NASAL DECONGESTANT PE 10 MG TB
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis